{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:15:46Z","timestamp":1792678546154,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a prototypical autoimmune disease characterized by chronic inflammation and immune dysregulation. Although Janus kinase (JAK) inhibitors such as tofacitinib have expanded therapeutic options, treatment responses remain heterogeneous and reliable predictors of efficacy are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Peripheral blood mononuclear cells (PBMCs) and serum samples were collected from 14 patients with active RA before initiation of tofacitinib treatment. Patients were classified as responders or non-responders according to EULAR DAS28 criteria after treatment. An integrative multi-omics approach was applied, including RNA sequencing, miRNA sequencing, proteomics, and untargeted metabolomics. Comprehensive bioinformatics analyses were performed to identify potential candidate predictors of tofacitinib response. Key findings were further assessed through internal validation in an independent cohort of tofacitinib-treated RA patients and external validation using publicly available datasets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multi-omics analyses revealed upregulation of ribosomal proteins in PBMCs of responders, with\n                      <jats:italic>RPL21<\/jats:italic>\n                      emerging as a potential immune-related candidate. Consistently, hsa-miR-197-3p and hsa-miR-625-3p were downregulated in responders, suggesting possible regulatory roles in treatment efficacy. Proteomic profiling showed decreased serum apolipoproteins, particularly APOA1, while metabolomic analysis identified elevated choline, malate, and nervonic acid, reflecting immune-metabolic reprogramming. Integration of multi-omics data highlighted convergent immune pathways and identified exploratory candidate biomarkers associated with tofacitinib response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides exploratory integrative multi-omics evidence linking immune-related transcriptomic, proteomic, and metabolic alterations to heterogeneous therapeutic responses in RA. The identified signatures improve our understanding of molecular pathways underlying JAK inhibition response and offer potential candidate biomarkers to guide personalized treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1703209","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:32:46Z","timestamp":1769423566000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-omics identification of immune-related biomarkers predicting tofacitinib response in rheumatoid arthritis"],"prefix":"10.3389","volume":"16","author":[{"given":"Fangyi","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshu","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Chen","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Qilu Hospital, Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa845","article-title":"tREACH group investigators. The impact of different (rheumatoid) arthritis phenotypes on patients\u2019 lives","volume":"60","author":"Luurssen-Masurel","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13075-019-1866-2","article-title":"Safety and efficacy of tofacitinib for up to 9.5\u2009years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study","volume":"21","author":"Wollenhaupt","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220795","article-title":"Baseline gene expression analysis in the peripheral blood of patients with rheumatoid arthritis as an important supplement to standard composite measure","volume":"50","author":"Tchetina","year":"2023","journal-title":"J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2025.06.001","article-title":"Exploring AI tools and multi-omics for precision medicine in lung cancer therapy","volume":"84","author":"Sahu","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1005457","DOI":"10.1371\/journal.pcbi.1005457","article-title":"Transcriptomics technologies","volume":"13","author":"Lowe","year":"2017","journal-title":"PloS Comput Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/ar3819","article-title":"The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients","volume":"14","author":"Raterman","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.38400","article-title":"Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray","volume":"66","author":"Sanayama","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41232-018-0078-5","article-title":"Transcriptome analysis of peripheral blood from patients with rheumatoid arthritis: a systematic review","volume":"38","author":"Sumitomo","year":"2018","journal-title":"Inflammation Regen"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00330-y","article-title":"A molecular signature response classifier to predict inadequate response to tumor necrosis factor-\u03b1 Inhibitors: the NETWORK-004 prospective observational study","volume":"8","author":"Cohen","year":"2021","journal-title":"Rheumatol Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-06931-6","article-title":"Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters","volume":"43","author":"Lu","year":"2024","journal-title":"Clin Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jprot.2018.12.012","article-title":"Proteomics turns functional","volume":"198","author":"Monti","year":"2019","journal-title":"J Proteomics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted metabolomics strategies-challenges and emerging directions","volume":"27","author":"Schrimpe-Rutledge","year":"2016","journal-title":"J Am Soc Mass Spectrom"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/g2v2ae","article-title":"High-throughput RNA-sequencing reveals novel targets of tofacitinib in the treatment of rheumatoid arthritis","volume":"41","author":"Chen","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00018-024-05196-1","article-title":"Macrophage re-programming by JAK inhibitors relies on MAFB","volume":"81","author":"L\u00f3pez-Navarro","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158327","article-title":"JAK inhibitors in rheumatoid arthritis: immunomodulatory properties and clinical efficacy","volume":"25","author":"Kie\u0142bowski","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2025.2464457","article-title":"Early diagnosis of rheumatoid arthritis: associations between patients\u2019 perceptions of initial symptoms and the timing of seeking help from the general practitioner","volume":"54","author":"Pedersen","year":"2025","journal-title":"Scand J Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"20230393","DOI":"10.1098\/rstb.2023.0393","article-title":"Ribosomes: from conserved origin to functional\/medical mobility and heterogeneity","volume":"380","author":"Rivalta","year":"2025","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(11)80413-4","article-title":"Characterization of eukaryotic protein L7 as a novel autoantigen which frequently elicits an immune response in patients suffering from systemic autoimmune disease","volume":"192","author":"von Mikecz","year":"1994","journal-title":"Immunobiology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2000.01132.x","article-title":"Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer","volume":"50","author":"Yamamoto","year":"2000","journal-title":"Pathol Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.1259077","article-title":"Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease","volume":"346","author":"Ito","year":"2014","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"23899","DOI":"10.1038\/s41598-024-74728-3","article-title":"Revealing disease subtypes and heterogeneity in common variable immunodeficiency through transcriptomic analysis","volume":"14","author":"Zabihi","year":"2024","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147501","article-title":"Development of a novel immune infiltration-related diagnostic model for Alzheimer\u2019s disease using bioinformatic strategies","volume":"14","author":"Zhuang","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01730","article-title":"RPL21 siRNA blocks proliferation in pancreatic cancer cells by inhibiting DNA replication and inducing G1 arrest and apoptosis","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s11658-023-00443-y","article-title":"RPL21 interacts with LAMP3 to promote colorectal cancer invasion and metastasis by regulating focal adhesion formation","volume":"28","author":"Zhu","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4380-z","article-title":"MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis","volume":"38","author":"Singh","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3899\/jrheum.170266","article-title":"Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial","volume":"45","author":"Sode","year":"2018","journal-title":"J Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1027758","article-title":"A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study","volume":"9","author":"Shadbad","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1133598","article-title":"Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer","volume":"13","author":"Horak","year":"2023","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12014-023-09411-2","article-title":"Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop","volume":"20","author":"Chen","year":"2023","journal-title":"Clin Proteomics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-09665-0_14","article-title":"Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions","volume":"224","author":"Montecucco","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105683","article-title":"Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study","volume":"91","author":"Raadsen","year":"2024","journal-title":"Joint Bone Spine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e70188","DOI":"10.1111\/1756-185X.70188","article-title":"Regulating rheumatoid arthritis from the perspective of metabolomics: A comprehensive review","volume":"28","author":"Liang","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003180","article-title":"Choline transport links macrophage phospholipid metabolism and inflammation","volume":"293","author":"Snider","year":"2018","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205696","article-title":"Choline kinase inhibition in rheumatoid arthritis","volume":"74","author":"Guma","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12263-024-00756-3","article-title":"Visnagin alleviates rheumatoid arthritis via its potential inhibitory impact on malate dehydrogenase enzyme: in silico, in vitro, and in vivo studies","volume":"19","author":"Khamis","year":"2024","journal-title":"Genes Nutr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jare.2024.08.028","article-title":"Nervonic acid triggered ovarian inflammation by inducing mitochondrial oxidative stress to activate NLRP3\/IL-1\u03b2 pathway","volume":"73","author":"Zeng","year":"2025","journal-title":"J Adv Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1703209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:12:14Z","timestamp":1771924334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1703209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2025.1703209"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1703209","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"article-number":"1703209"}}